HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE
Approval overview HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 088587 (ANDA).
Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE Form and strength SOLUTION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2001-10-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 088587 (ANDA). Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE Form and strength SOLUTION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2001-10-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.